Literature DB >> 7857698

Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis.

J Ashby1, A Brady, C R Elcombe, B M Elliott, J Ishmael, J Odum, J D Tugwood, S Kettle, I F Purchase.   

Abstract

In this review we have evaluated the relationship between peroxisome proliferation and hepatocarcinogenesis. To do so, we identified all chemicals known to produce peroxisome proliferation and selected those for which there are data (on peroxisome proliferation and hepatocarcinogenesis) which meet certain criteria chosen to facilitate comparison of these phenomena. The summarised data and definition of the methodology used has been collected in appendices. These comparisons enabled us to evaluate the relationship between these phenomena using reliable data. As there is a good correlation between them, we further explored the mechanisms of action that have been proposed (direct genotoxic activity, production of hydrogen peroxide, cell proliferation and receptor activation). The relationship between these events in other species, including humans, was also reviewed and finally an overview of the assessment of human hazard is presented in section IX. Some of the first chemicals which were shown to produce peroxisome proliferation were also hepatocarcinogens whose carcinogenicity could not be readily explained by genotoxic activity. This raised the suggestion that the unusual phenomenon of peroxisome proliferation was intricately linked to the carcinogenic activity of these agents. Three questions have exercised the attention of regulatory, industrial and academic toxicology since then; are chemicals which elicit peroxisome proliferation in the liver actually a coherent class of chemical carcinogens?; does the early biological phenomenon of peroxisome proliferation have real predictive value for and mechanistic association with rodent carcinogenesis?; and what hazard/risk do these agents pose to humans that may be exposed to them? Whether peroxisome proliferators are indeed a discrete class of rodent carcinogens would appear to be the single, most important question. If so, then the assumptions and procedures relevant to human hazard and risk assessment should be applied to the class and should be essentially generic; if not, each chemical should be considered independently. Our critical analysis of the published data for over 70 agents which have been shown to possess intrinsic ability to induce peroxisome proliferation in the livers of rodents has led to the conclusion that there exists a strong correlation between peroxisome proliferation as n early effect in the liver and hepatocarcinogenicity in chronic exposure studies. An almost perfect correlation was observed between the induction of peroxisomes in the rodent liver and the eventual appearance of tumours following chronic exposure The few exceptions to this were largely explainable (section II).(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7857698     DOI: 10.1177/096032719401300201

Source DB:  PubMed          Journal:  Hum Exp Toxicol        ISSN: 0960-3271            Impact factor:   2.903


  28 in total

1.  Peroxisome proliferators and peroxisome proliferator-activated receptor alpha: biotic and xenobiotic sensing.

Authors:  Janardan K Reddy
Journal:  Am J Pathol       Date:  2004-06       Impact factor: 4.307

2.  Differential susceptibility of mice humanized for peroxisome proliferator-activated receptor alpha to Wy-14,643-induced liver tumorigenesis.

Authors:  Keiichirou Morimura; Connie Cheung; Jerrold M Ward; Janardan K Reddy; Frank J Gonzalez
Journal:  Carcinogenesis       Date:  2005-12-24       Impact factor: 4.944

3.  Intestinal PPARα Protects Against Colon Carcinogenesis via Regulation of Methyltransferases DNMT1 and PRMT6.

Authors:  Yuhong Luo; Cen Xie; Chad N Brocker; Jie Fan; Xuan Wu; Lijin Feng; Qiong Wang; Jie Zhao; Dasheng Lu; Mayank Tandon; Maggie Cam; Kristopher W Krausz; Weiwei Liu; Frank J Gonzalez
Journal:  Gastroenterology       Date:  2019-05-30       Impact factor: 22.682

Review 4.  Xenobiotic metabolism, disposition, and regulation by receptors: from biochemical phenomenon to predictors of major toxicities.

Authors:  Curtis J Omiecinski; John P Vanden Heuvel; Gary H Perdew; Jeffrey M Peters
Journal:  Toxicol Sci       Date:  2010-11-08       Impact factor: 4.849

5.  A critical role for peroxisomal proliferator-activated receptor-alpha nuclear receptors in the development of cardiomyocyte degeneration and necrosis.

Authors:  Ingrid Pruimboom-Brees; Mehrdad Haghpassand; Lori Royer; Dominique Brees; Charles Aldinger; William Reagan; Jatinder Singh; Roy Kerlin; Christopher Kane; Scott Bagley; Cheryl Hayward; James Loy; Peter O'Brien; Omar L Francone
Journal:  Am J Pathol       Date:  2006-09       Impact factor: 4.307

6.  In vitro cytogenetic toxicity of bezafibrate in human peripheral blood lymphocytes.

Authors:  M Topaktas; N E Kafkas; S Sadighazadi; E S Istifli
Journal:  Cytotechnology       Date:  2017-01-17       Impact factor: 2.058

7.  Effects of rosiglitazone treatment on the pentose phosphate pathway and glutathione-dependent enzymes in liver and kidney of rats fed a high-fat diet.

Authors:  Esen Akbay; Nuriye Nuray Ulusu; Füsun Töröner; Göksun Ayvaz; Ferit Taneri; Müjde Aktürk; Metin Arslan; Cimen Karasu
Journal:  Curr Ther Res Clin Exp       Date:  2004-01

8.  Molecular basis of non-responsiveness to peroxisome proliferators: the guinea-pig PPARalpha is functional and mediates peroxisome proliferator-induced hypolipidaemia.

Authors:  A R Bell; R Savory; N J Horley; A I Choudhury; M Dickins; T J Gray; A M Salter; D R Bell
Journal:  Biochem J       Date:  1998-06-15       Impact factor: 3.857

9.  The Role of PPARα Activation in Liver and Muscle.

Authors:  Lena Burri; G Hege Thoresen; Rolf K Berge
Journal:  PPAR Res       Date:  2010-08-18       Impact factor: 4.964

Review 10.  A reexamination of the PPAR-alpha activation mode of action as a basis for assessing human cancer risks of environmental contaminants.

Authors:  Kathryn Z Guyton; Weihsueh A Chiu; Thomas F Bateson; Jennifer Jinot; Cheryl Siegel Scott; Rebecca C Brown; Jane C Caldwell
Journal:  Environ Health Perspect       Date:  2009-05-15       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.